Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 146Carcinoma, Non-Small-Cell Lung 112Carcinoma, Renal Cell 74Neoplasm Metastasis 53Carcinoma, Hepatocellular 51Squamous Cell Carcinoma of Head and Neck 50Lung Neoplasms 48Colorectal Neoplasms 34Pancreatic Neoplasms 30Neoplasms 30Hodgkin Disease 30Urinary Bladder Neoplasms 24Sarcoma 23Brain Neoplasms 23Stomach Neoplasms 22Head and Neck Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Carcinoma, Transitional Cell 20Glioblastoma 19Recurrence 17Colonic Neoplasms 17Kidney Neoplasms 16Uveal Melanoma 15Small Cell Lung Carcinoma 15Multiple Myeloma 15Esophageal Neoplasms 15Carcinoma, Squamous Cell 14Skin Neoplasms 13Leukemia, Myeloid, Acute 13

Interventions

entecavir 7Lamivudine 3Tenofovir 2peginterferon alfa-2b 1lenvatinib 1bicyclol 1adefovir 1Urinalysis 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Telbivudine 1Tablets 1Rapid Diagnostic Tests 1Radiomics 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pharmaceutical Preparations 1Nucleosides 1Nivolumab 1Interferons 1Hypothermia, Induced 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Cyclophosphamide 1Control Groups 1Cognitive Behavioral Therapy 1Cholecalciferol 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hepatitis B × Nivolumab × Clear all
NCT04044651 2020-01-09

Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

Sun Yat-sen University

Phase 2/3 Withdrawn
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡